Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1974 Jan;26(1):205–215.

Serum factors responsible for killing of Shigella

W P Reed, Elizabeth L Albright
PMCID: PMC1423117  PMID: 4846468

Abstract

Eight strains of Shigella were tested for susceptibility to killing by seven normal human sera. Although there was a wide range of susceptibility between strains of bacteria, there was surprisingly little difference in the killing activity of individual sera and no relationship between antibody titres and killing capacity.

Bacteriolysis required small amounts of antibody, but as little as 0.02 mg of a 19S fraction from normal serum restored full killing capacity to 1 ml of antibody depleted serum. Neither 11S IgA nor Cohn fraction II restored the bacteriolytic ability. Both the early reacting complement sequence and the alternate C3 activating pathway appeared to participate in killing as indicated by the roles of C2 and C3PA. Killing occurred, but with reduced efficiency, when either of the two substances was missing. However, serum lacking both C2 and C3PA could no longer kill Shigella. Killing also required the presence of C3, and presumably some of the later components of complement are subsequently involved.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., De Bracco M. M., Kunkel H. G. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol. 1972 Mar;108(3):837–840. [PubMed] [Google Scholar]
  2. Ensky J., Hinz C. F., Jr, Todd E. W., Wedgwood R. J., Boyer J. T., Lepow I. H. Properties of highly purified human properdin. J Immunol. 1968 Jan;100(1):142–158. [PubMed] [Google Scholar]
  3. Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968 Nov 1;128(5):1049–1057. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Glynn A. A., Howard C. J. The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology. 1970 Mar;18(3):331–346. [PMC free article] [PubMed] [Google Scholar]
  5. Hewstone A. S., Whitaker J. The correlation of ureteric urine bacteriology and homologous antibody titer in children with urinary infection. J Pediatr. 1969 Apr;74(4):540–543. doi: 10.1016/s0022-3476(69)80036-3. [DOI] [PubMed] [Google Scholar]
  6. Jasin H. E. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation. J Immunol. 1972 Jul;109(1):26–31. [PubMed] [Google Scholar]
  7. Johnson F. R., Agnello V., Williams R. C., Jr Opsonic activity in human serum deficient in C2. J Immunol. 1972 Jul;109(1):141–145. [PubMed] [Google Scholar]
  8. Lee M. R., Ikari N. S., Branche W. C., Jr, Young V. M. Microtiter bacterial hemagglutination technique for detection of Shigella antibodies. J Bacteriol. 1966 Jan;91(1):463–463. doi: 10.1128/jb.91.1.463-.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. OSAWA E., MUSCHEL L. H. The bactericidal action of normal serum and the properdin system. J Immunol. 1960 Feb;84:203–212. [PubMed] [Google Scholar]
  11. Phillips J. K., Snyderman R., Mergenhagen S. E. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. J Immunol. 1972 Aug;109(2):334–341. [PubMed] [Google Scholar]
  12. Reed W. P., Williams R. C., Jr Intestinal immunoglobulins in shigellosis. Gastroenterology. 1971 Jul;61(1):35–45. [PubMed] [Google Scholar]
  13. WARDLAW A. C., PILLEMER L. The properdin system and immunity. V. The bactericidal activity of the properdin system. J Exp Med. 1956 May 1;103(5):553–575. doi: 10.1084/jem.103.5.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wernet P., Breu H., Knop J., Rowley D. Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis. 1971 Aug;124(2):223–226. doi: 10.1093/infdis/124.2.223. [DOI] [PubMed] [Google Scholar]
  15. Williams R. C., Jr, Quie P. G. Opsonic activity of agammaglobulinemic human sera. J Immunol. 1971 Jan;106(1):51–55. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES